Design always adapts to the human body
Architecture and product design have historically responded to changes in human physiology. Door heights increased as populations grew taller. Airline seats widened as average body mass increased. Furniture and building codes rely on anthropometric data to define clearances and comfort.
Now, GLP-1 drugs may mark a reversal of those trends.
Often referred to by brand names like Ozempic or Wegovy, GLP-1 drugs are changing how millions of Americans eat and how kitchens are designed to support those habits. GLP-1 receptor agonists, a class of drugs widely prescribed for diabetes and weight loss, are changing how millions of Americans eat. Smaller portions, fewer meals and greater focus on protein and nutrient-dense foods are reshaping daily routines. This week we sought out to answer a couple of questions: How great of an impact will the ozempic-boom have on kitchen design? And are designers and manufactures working in the space already seeing it’s effects?
